ÎÚÑ»´«Ã½

Jump to Main Content

Clinicians

CME and MOC Information

The ÎÚÑ»´«Ã½ (ASH) is accredited by the Accreditation Council for Continuing Medical ÎÚÑ»´«Ã½ (ACCME) to provide continuing medical education (CME) for physicians.

ASH LIVE EVENTS OFFERING CME/MOC

ASH Annual Meeting and Exposition

To claim credit and print certificates of participation, attendees must complete the evaluation surveys through the website by April 11, 2025.

Additional CME details can be found in the expandable header below:

The deadline to claim CME/MOC is April 11, 2025.

If you did not pay the $30 CME fee during the registration process and wish to claim CME and/or MOC, you will be prompted to pay it when you select the CME option on the Annual Meeting Evaluation Surveys.

EDUCATIONAL OBJECTIVES
Upon completion of this educational activity, participants should be able to: 

  • Employ the knowledge gained regarding the diagnosis and treatment of classical and malignant hematologic disorders to improve patient care
  • Discuss state-of-the-art research in hematology; and
  • Analyze the potential contribution of novel, not-yet-approved modalities of therapy to current evidence-based management of hematologic disorders.

ACCREDITATION AND CREDIT DESIGNATION
The ÎÚÑ»´«Ã½ is accredited by the Accreditation Council for Continuing Medical ÎÚÑ»´«Ã½ to provide continuing medical education for physicians.

ASH designates this Other (blended live and on-demand) educational activity for a maximum of 95 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

QUALIFYING SESSIONS
Physician attendees can claim CME for viewing qualifying live sessions as they are broadcast or after they have concluded. Accredited sessions will be labeled in the print and online meeting materials, as well as in on-site digital signage.

CME CERTIFICATE ELIGIBILITY
ASH is accredited to provide AMA PRA Category 1 Credits™ to physicians only. The American Medical Association (AMA) defines physicians as those individuals who have obtained an MD, DO, or equivalent medical degree from another country. Physicians not licensed in the United States who participate in this CME activity are also eligible for AMA PRA Category 1 Credits™.

HOW TO OBTAIN CME CREDIT
A processing fee of $30 will be charged for CME certificates. Physician attendees may and print their CME certificates through the ASH website by clicking the Annual Meeting CME link on the homepage. Attendees may print a Session Summary listing of all the accredited sessions they participated in. The online process for claiming CME credits and printing a CME certificate for the 66th ASH Annual Meeting must be completed no later than April 11, 2025.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 95.00 Maintenance of Certification (MOC) points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

HOW TO OBTAIN ABIM MOC POINTS
Once participants have completed their CME credit claim, they will be asked to submit a reflective statement on how they intend to change their practice based on the knowledge gained from participation in the meeting. Participants must include their ABIM number and month and day of birth. Upon review and approval, points will be submitted to the ACCME by ASH and will appear in the ABIM Physician Portal within 48 hours. To receive ABIM MOC points for the 66th ASH Annual Meeting, the online process for claiming CME/ABIM MOC credits must be completed by April 11, 2025. Participants must complete these steps to earn MOC points. Otherwise, participants will not have met all requirements and points will not be registered with ABIM.

CERTIFICATE OF PARTICIPATION
Non-physicians and other health-care professionals attending the meeting can . Attendees may print a Session Summary listing of all the accredited sessions they participated in. The online process of filling out the annual meeting survey and printing the certificate must be completed no later than April 11, 2025. There is no charge to meeting attendees for this service.

EUROPEAN BOARD FOR ACCREDITATION IN HEMATOLOGY
The 66th ASH Annual Meeting and Exposition has been reviewed and approved for CME-CPD accreditation by the European Board for Accreditation in Hematology (EBAH). The EBAH has approved this educational activity for a maximum number of 28 CME-CPD credits. Each participant should only collect credits for time that she/he actually spent in the educational activity. To claim EBAH-CME credit for attending the meeting, ensure the EBAH CME credit box is checked and complete the online evaluation. The list of people seeking EBAH credit will be submitted to EBAH monthly. There is no fee required to be eligible for EBAH-CME credit points. For information about EBAH CME-CPD, visit the EBAH website. 

CONFLICT-OF-INTEREST POLICY FOR THE ASH ANNUAL MEETING
ASH is committed to providing quality, objective, balanced, and scientifically rigorous continuing medical education activities that are free from commercial and non-commercial bias. In accordance with the rules of the Accreditation Council for Continuing Medical ÎÚÑ»´«Ã½ (ACCME), ASH policy requires that all meeting session chairs, speakers, and moderators disclose in writing prior to the meeting any financial relationships they may hold with companies in the healthcare and biotechnology industries. Poster presenters are likewise required to disclose in writing any financial relationships they may have prior to the meeting and display their disclosures as a part of their poster presentation. If bias, actual or perceived, occurs during the presentations, session attendees are encouraged to address such bias during the question-and-answer periods following the presentations.

All ASH annual meeting presenters (including invited chairs and speakers, and abstract presenters and moderators) are asked to disclose any relationships of the following types: Employment, Consultancy, Stock Ownership, Stock Options, Research Funding, Honoraria, Patents & Royalties, Speakers Bureau, ÎÚÑ»´«Ã½ on an entity’s Board of Directors or advisory committee, and any other financial relationship including Travel Support.

Disclosure Policy

In accordance with the ACCME Standards for Commercial Support, the ÎÚÑ»´«Ã½ (ASH) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. ASH mitigates all relevant financial relationships with commercial interests to ensure independence, objectivity, balance, and scientific rigor in all educational programs. Furthermore, ASH seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. ASH is committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of commercial interest. ASH staff who control content have no relevant financial relationships to disclose.

Review planner disclosure information

Review speaker disclosure information

Any questions about this policy or concerns regarding disclosures should be directed to [email protected].

NON-CME SESSIONS
ASH is committed to continuously re-evaluating our policies and processes to ensure that they align with the Accreditation Council for Continuing Medical ÎÚÑ»´«Ã½’s (AACME) increasingly stringent standards. The ACCME defines Ineligible Companies (IC), also known as commercial interests, as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Pharmaceutical and biotechnology companies, including biomedical startups and diagnostic laboratories with proprietary products, are classified as ineligible companies and, per ACCME, any presentation given by employees of industry is considered to be promotional in nature and therefore ineligible to be accredited.

There are a number of programs and sessions in the program that are not accredited for CME. Please note that oral and poster abstracts are no longer included in the accredited programming.

The final list of non-CME sessions is subject to change. Accredited sessions will be labeled on the virtual platform and an up-to-date list of sessions will also be available.

Highlights of ASH

The Highlights of ASH® in North America features the world’s leading hematologic experts during a two-day program that highlights the most influential research presented at the latest ASH annual meeting, the premier event in malignant and classical (non-malignant) hematology. By attending Highlights of ASH, you will get a comprehensive review of significant scientific updates in clinical and translational hematologic research, learn how these updates directly affect the study and practice of hematology, and discover how new research can be translated into cutting-edge patient care.

ACCREDITATION STATEMENT

The ÎÚÑ»´«Ã½ (ASH) is accredited by the Accreditation Council for Continuing Medical ÎÚÑ»´«Ã½ (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION

ASH designates this live educational activity for a maximum of 13.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Attendees can claim credit for attending one of the in-person events in the following cities:

  • Seattle, WA
  • Chicago, IL
  • Washington, DC
  • New York, NY

CME CERTIFICATE ELIGIBILITY

ASH is accredited to provide AMA PRA Category 1 Credits™ to physicians only. The American Medical Association (AMA) defines physicians as those individuals who have obtained an MD, DO, or equivalent medical degree from another country. Physicians not licensed in the United States who participate in this CME activity are also eligible for AMA PRA Category 1 Credits™.

CERTIFICATE OF PARTICIPATION

Non-physicians and other health care professionals attending the accredited activity may receive a Certificate of Participation.

ABIM MOC POINTS

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 13.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

HOW TO OBTAIN CME/MOC CREDIT

To qualify for CME credits, participants are required to fill out the program evaluation surveys through your account on , which will become accessible closer to the event. Once you have completed the survey, you will be able to print and/or save your certificate as proof of attendance.

 

For ABIM MOC points,in additionto completing the evaluation survey, you must include your ABIM number and date of birth on your profile and submit a reflective statement outlining your commitment to implementing the knowledge gained from your participation in the meeting into your practice. Upon review and approval of the statement, points will be submitted to the ABIM by ASH. Points will only be submitted if you provide all the requested information.

 

HOW TO OBTAIN A CERTIFICATE OF PARTICIPATION

Non-physicians may receive a Certificate of Participation documenting their attendance in the accredited CME activity through the online evaluation module on ASH Academy On Demand. Upon completion of the evaluation, participants may print/save their certificate. ASH will send an email with instructions on how to download the certificate following the activity.

The deadline to claim CME/MOC or request a certificate of attendance is April 30, 2025.


DISCLOSURE POLICY

In accordance with the ACCME Standards for Commercial Support, the ÎÚÑ»´«Ã½ (ASH) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. ASH resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all educational programs. Furthermore, ASH seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. ASH is committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of commercial interest.

DISCLOSURE OF UNLABELED USE

ASH requires CME faculty (speakers) to disclose when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that are outside of US Food and Drug Administration-approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. ASH does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information. ASH staff who control content have no relevant financial relationships to disclose.

Other CME/MOC Opportunities

This comprehensive educational resource offers up-to-date information in adult and pediatric hematology for internists, hematologists, pediatricians, and hematology/oncology fellows. The ASH-SAP, 8th Edition, includes a textbook with 25 chapters, as well as 258 case-based, multiple-choice questions grouped into six themed tests. The tests combine to offer 75 AMA PRA Category 1 Creditsâ„¢ and 75 ABIM MOC Medical Knowledge Points. .

Blood Articles

Through a partnership with Medscape, ASH provides an opportunity for hematologists to earn CME credit by testing their comprehension of . A new CME article appears in the journal the third week of every month. Credits vary depending on the article, and there is no charge to participants to earn CME credit.

Please note that CME for this activity is not administered through ASH Academy On Demand. This activity is administered by Medscape, a continuing medical education company.

ASH Academy On Demand

, the eLearning platform for hematologists, provides the most current practice tools, clinical support, and educational products to meet the continuing education needs of hematologist professionals at every stage in their careers.

In order to claim CME/MOC credit or to request a certificate of attendance, participants must complete the online program evaluation associated with the activity. ASH keeps a rolling record of the past six years of claimed credits for its CME-accredited activities.

ASH is accredited to provide AMA PRA Category 1 Creditsâ„¢ to physicians only. The American Medical Association (AMA) defines physicians as those individuals who have obtained an MD, DO, or equivalent medical degree from another country. Non-physicians may request a certificate of attendance for their participation in a CME activity. All certificates are issued in PDF format.

Hematology 2023

The Hematology ASH ÎÚÑ»´«Ã½ Program is an annual publication that provides practicing hematologists with invaluable information on the most important areas of clinical progress.

Hematology 2023 is a peer-reviewed collection of articles written by the 2023 ASH ÎÚÑ»´«Ã½ Program speakers and the Ham-Wasserman Lecturer. The papers showcase groundbreaking advances and new concepts in 31 different fields. Every year, the periodical provides an updated and comprehensive review of each of the topics covered in the annual meeting education sessions.

ÎÚÑ»´«Ã½al Objectives

  1. Employ the knowledge gained regarding the diagnosis and treatment of malignant and classical hematologic disorders to improve patient care.
  2. Discuss the state-of-the-art therapeutics in hematology.
  3. Analyze the potential contribution of novel, not-yet-approved modalities of therapy to current evidence-based management of malignant and classical hematologic disorders. 

DATE OF RELEASE

December 2023

DATE OF EXPIRATION
On December 31, 2024, the ability to earn Continuing Medical ÎÚÑ»´«Ã½ credit and American Board of Internal Medicine Maintenance of Certification Medical Knowledge points for this product expires. This is the last date for users to claim credit for this product. For questions about credit, please contact the ASH ÎÚÑ»´«Ã½ Department at [email protected] or call 866-828-1231 (toll-free) within the United States only or 1-202-776-0544 internationally.

Hematology 2023 Editor and Planner Disclosures

In accordance with the rules of the Accreditation Council for Continuing Medical ÎÚÑ»´«Ã½ (ACCME), ASH policy requires that all Hematology 2023 editors and planners disclose in writing, any financial relationships they may hold with companies in the healthcare and biotechnology industries. They are asked to disclose any relationships of the following types: Employment, Consultancy, Stock Ownership, Research Funding, Honoraria, Patents & Royalties, Speakers Bureau, ÎÚÑ»´«Ã½ on an entity’s Board of Directors or advisory committee, and any other financial relationship including Travel Support. These financial relationships are available for learners to review. 

Review Hematology 2023 Planner and Editor Disclosures

Commercial Support

This activity is supported by educational grants from AstraZeneca; GlaxoSmithKline; Incyte Corp.; Jazz Pharmaceuticals, Inc.; Merck Sharp & Dohme Corp.; and Novartis Pharmaceuticals Corp.

ACCREDITATION AND CREDIT DESIGNATION
The ÎÚÑ»´«Ã½ (ASH) is accredited by the Accreditation Council for Continuing Medical ÎÚÑ»´«Ã½ (ACCME) to provide continuing medical education for physicians.

ASH designates this journal-based CME activity for a maximum of 40 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians who participate in this CME activity but are not licensed in the United States are also eligible for AMA PRA Category 1 CreditTM. To earn these credits, readers must pass two online tests (malignant and classical) based on articles from Hematology 2023.

ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 40 MOC points in the ABIM’s MOC program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

CLAIMING CME CREDITS AND ABIM POINTS
The estimated time to complete this educational activity is 40 hours. To claim CME credit, users must complete an evaluation of the product and a test of medical knowledge, both of which are accessed through ASH Academy on Demand (). There is a one-time processing fee for claiming CME/MOC credit. Users with scores of 80% or better on these self-assessment modules are eligible to claim credit for the activity.

To facilitate claiming of credit, the test for this product is divided into two subtests, one of which focuses on malignant hematology content with the other focusing on classical content. Successful completion of each test earns the user 20 AMA PRA Category 1 CreditsTM. Users claim CME and/or ABIM MOC credit for each test individually. You can take one or both tests, depending on your CME and MOC needs.

The malignant and classical hematology tests consist of 20 questions each. The questions in each test can be answered in one sitting, or a user can save their progress and return to complete the test at a later time.

Hematology 2024

°Õ³ó±ð Hematology ASH ÎÚÑ»´«Ã½ Program is an annual publication that provides practicing hematologists with invaluable information on the most important areas of clinical progress.

Hematology 2024 is a peer-reviewed collection of articles written by the 2024 ASH ÎÚÑ»´«Ã½ Program speakers and the Ham-Wasserman Lecturer. The papers showcase groundbreaking advances and new concepts in 31 different fields. Every year, the periodical provides an updated and comprehensive review of each of the topics covered in the annual meeting education sessions. The publication is supplemented by two online knowledge tests based on the articles from each edition.

EDUCATIONAL OBJECTIVES

  1. Employ the knowledge gained regarding the diagnosis and treatment of malignant and classical hematologic disorders to improve patient care.
  2. Discuss the state-of-the-art therapeutics in hematology.
  3. Analyze the potential contribution of novel, not-yet-approved modalities of therapy to current evidence-based management of malignant and classical hematologic disorders.

Date of Release

December 2024

Date of Expiration

On December 31, 2025, the ability to earn Continuing Medical ÎÚÑ»´«Ã½ credit and American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) Medical Knowledge points for this product expires. This is the last date for learners to claim credit for this product. For questions about credit, please contact the ASH ÎÚÑ»´«Ã½ Department at [email protected] or call 866-828-1231 (toll-free) within the United States only or 1-202-776-0544 internationally.

Hematology 2024 Editor and Planner Disclosures

In accordance with the rules of the Accreditation Council for Continuing Medical ÎÚÑ»´«Ã½ (ACCME), ASH policy requires that all Hematology 2024 editors and planners disclose in writing, any financial relationships they may hold with companies in the healthcare and biotechnology industries. They are asked to disclose any relationships of the following types: Employment, Consultancy, Stock Ownership, Research Funding, Honoraria, Patents & Royalties, Speakers Bureau, ÎÚÑ»´«Ã½ on an entity’s Board of Directors or advisory committee, and any other financial relationship including Travel Support. These financial relationships are available for learners to review. 

Review Hematology 2024 Planner and Editor Disclosures

Commercial Support

This activity is supported by educational grants from AstraZeneca Pharmaceuticals, GlaxoSmithKline, and Novartis Pharmaceuticals Corporation. 

Online Knowledge Tests

The associated online knowledge tests allow learners to measure their competence against the stated learning objectives. The test for this activity is divided into two subtests with 20 questions each, one of which focuses on malignant hematology content with the other focusing on classical content. Learners may complete a test in one sitting or save their progress and return to complete the test at a later time. The knowledge tests are accessed through ASH Academy On Demand (). There is a one-time processing fee for accessing the tests.

ACCREDITATION AND CREDIT DESIGNATION

The ÎÚÑ»´«Ã½ (ASH) is accredited by the Accreditation Council for Continuing Medical ÎÚÑ»´«Ã½ (ACCME) to provide continuing medical education for physicians.

ASH designates this journal-based CME activity for a maximum of 40 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians who participate in this CME activity but are not licensed in the United States are also eligible for AMA PRA Category 1 CreditTM. To earn these credits, readers must pass two online tests (malignant and classical) based on articles from Hematology 2024.

ABIM MOC

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 40 MOC points in the ABIM’s MOC program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

CLAIMING CME CREDITS AND ABIM POINTS

The estimated time to complete this educational activity is 40 hours. Learners with scores of 80% or better on these knowledge tests are eligible to claim credit for the activity. Successful completion of each test earns the learner 20 AMA PRA Category 1 CreditsTM. Learners claim CME and/or ABIM MOC credit for each test individually.  

Questions?

For questions or requests for additional information, please contact [email protected].